$LEVI

Haas Robert D. sold $4.5M of LEVI (indirect holdings)

Haas Robert D. sold 198,283 indirectly-held shares of LEVI STRAUSS & CO (LEVI) at an average of $22.72 ($22.68–$24.00, $4.51M total) across 2 trades over 2026-05-26 to 2026-05-27 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Haas Robert D.
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:44 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LEVI
Neutral
high confidence
Mentioned
$LEVI
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LEVINeutralLow
01

Why it matters

The only new information is the disclosed sale size, price range, and that post-transaction holdings are 0 shares; there is no guidance, deal, or regulatory action.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 framing and lack of fundamental updates make it unlikely to drive a durable repricing.

03

What to watch

The article does not disclose motivations, tax considerations, or whether other insiders have offsetting buys; without that, signal quality is low.

Relevance 5/10Novelty 3/10Timing: Filed 2026-05-28, covering sales on 2026-05-26 to 2026-05-27

Background

The article is an SEC Form 4 insider transaction disclosure for LEVI, reported by 10% owner Robert D. Haas with a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$LEVINeutralHigh confidence
Context

LEVI disclosed via Form 4 that 10% owner Robert D. Haas sold 198,283 shares in open-market transactions for about $4.51M.

Expected impact

Likely limited near-term impact; any effect is more about sentiment than fundamentals.

Evidence & confidence

The filing is an SEC Form 4 insider transaction, explicitly marked as a pre-arranged 10b5-1 plan, and provides no new company-specific news beyond the sale.

Market effects

Minimal; insider sales do not typically reset sector expectations without accompanying fundamentals.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan and the holdings after transaction are 0 shares, it may reflect scheduled liquidity needs rather than bearish views.

Key entities

  • LEVI

    Levi Strauss & Co., the company whose shares were sold in the disclosed insider transaction.

  • Robert D. Haas

    10% owner who executed open-market sales under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LEVIHighAI 8/10

Levi's CEO admits the company missed the biggest jeans trend of the year

Levi Strauss & Co. (LEVI) CEO Michelle Gass admitted the company missed the U.S. shift to low-rise jeans during the back-to-school season, impacting its direct-to-consumer sales. Despite a 4% revenue increase to $1.6 billion in Q3, shares fell nearly 5%. Levi's has since refocused marketing on low-rise styles and expects full-year revenue growth of about 6%.

$LEVIMed

Levi Strauss CEO Sounds Alarm on Growing Competition in Denim Market

Levi Strauss reported mixed results: European revenue rose 4-5%, Asia saw 5-10% growth, and Signature brand revenue jumped 13%. The company raised its adjusted earnings forecast to $1.54-$1.56 per share but lowered its revenue growth outlook to ~7%. CEO Michelle Gass noted increased competition in the denim market, emphasizing the need for innovation to maintain market share.

$LEVIMed

BNP Paribas Exane raises Levi Strauss price target to $35

BNP Paribas Exane raised its price target for Levi Strauss (LEVI) to $35, citing strong revenue growth and margins. The company reported Q3 revenue of $1.6B, up 4.3%, and EPS of $0.48, beating some estimates. Analysts note challenges in direct-to-consumer sales but see long-term growth potential. Other firms adjusted targets, ranging from $22 to $27.